Shanghai, Jan.11, 2016 — The DeltaHealth China (DHC) Board is very pleased to announce Dr. Desmond Thio will be joining DHC as Chief Executive Officer (CEO), DeltaHealth HospitalShanghai and DeltaHealth ClinicHongqiao effective 1 January 2016. Dr. Desmond Thio will also be rejoining the board.
Dr. Desmond Thio is no stranger to DHC. He was a board member from December 2012 to April 2014 and stayed on as an adviser and close friend since. Mr. Daniel Auerbach, Chairman of DHC Board said, “Dr. Desmond Thio has developed a deep-rooted relationship with DeltaHealth through the many years of close cooperation. He has distinguished professional background, rich industry experience and outstanding leadership. Moreover, his experience as a physician fill him with strong passion and sense of mission for the China healthcare industry. Under his leadership, I believe DeltaHealth hospital will be built into a world-class and innovation-driven cardiovascular hospital and embarking on our mission as transforming the patient experience through uncompromising commitment to demonstrable quality outcomes and innovative patient service delivery.”
Dr. Desmond Thio holds a diploma in Electrical Engineering and Bachelor degree of Science in Mathematics from Dalhousie University. He received a Doctor’s degree in Medicine from Mundial University in 1986.He also holds a Master’s degree of Science in Preventive Medicine from Ohio State University and an MBA from University of South Australia. He recently received his PhD/DBA from University Versailles/INSEEC in Applied Economics with focus on China private healthcare system.
Prior to joining DeltaHealth China, Dr. Desmond Thio was the president and senior vice president of Healthcare Greater China of Philips, being responsible for strategic planning, business development and overall management. He was a senior executive in a number of global and regional pharmaceutical and medical device companies based in Hong Kong, Taiwan, Japan and the USA, etc.
DeltaHealth Hospital is scheduled to put into operation during the first half of 2016. In preparation for its opening, the management team is now intensely conducting testing of medical equipment, and recruitment and training of the medical team. As the first and only hospital with a consultation and advisory relationship with Columbia HeartSource in China, DeltaHealth is committed to bringing an innovative clinical model to China to better meet local patients’ needs for diverse and premium medical care.
DeltaHealth is an innovative healthcare provider primarily invested by Eight Roads and its affiliate Eight Roads Ventures China. As of now, it is also the first and the only hospital with a consultation and advisory relationship with Columbia HeartSource in China. Bringing together healthcare concepts and technologies of excellence from China and abroad, DeltaHealth is committed to building a personalized healthcare system in China with state-of-the-art disease management practices and international clinical standards, by fostering a highly professional team of clinicians, providing personalized services that “center around patients” through word-class comprehensive facilities, and creating brand new experience for Chinese patients, while contributing to enhancing the quality of medical service in China.